Last reviewed · How we verify
Glycopyrronium in Combination With Tropisetron — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Glycopyrronium in Combination With Tropisetron (Glycopyrronium in Combination With Tropisetron) — The Second Affiliated Hospital of Chongqing Medical University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Glycopyrronium in Combination With Tropisetron TARGET | Glycopyrronium in Combination With Tropisetron | The Second Affiliated Hospital of Chongqing Medical University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Glycopyrronium in Combination With Tropisetron CI watch — RSS
- Glycopyrronium in Combination With Tropisetron CI watch — Atom
- Glycopyrronium in Combination With Tropisetron CI watch — JSON
- Glycopyrronium in Combination With Tropisetron alone — RSS
Cite this brief
Drug Landscape (2026). Glycopyrronium in Combination With Tropisetron — Competitive Intelligence Brief. https://druglandscape.com/ci/glycopyrronium-in-combination-with-tropisetron. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab